Mon, March 2, 2020

Liana Moussatos Maintained (BMRN) at Buy with Decreased Target to $164 on, Mar 2nd, 2020

Liana Moussatos of Wedbush, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $175 to $164 on, Mar 2nd, 2020.

Liana has made no other calls on BMRN in the last 4 months.



There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 1 agrees with Liana's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • George Farmer of "BMO Capital" Initiated at Hold and Held Target at $94 on, Tuesday, January 28th, 2020


These are the ratings of the 2 analyists that currently disagree with Liana


  • Kennen MacKay of "RBC Capital" Upgraded from Hold to Buy on, Friday, January 24th, 2020
  • Gena Wang of "Barclays" Upgraded from Hold to Buy and Held Target at $98 on, Wednesday, November 27th, 2019